Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Alterity Therapeutics Limited has announced a new securities issue dated July 18, 2024, proposing to release a maximum of 75,220,800 ordinary fully paid shares under the ASX security code ATH. This move by the biotechnology firm aims to strengthen its financial position through a placement or other type of securities issuance. The announcement signals potential growth opportunities for investors in the stock market.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.
